Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) (Middle Region) Peptide

CHUK Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5513207

Aperçu rapide pour conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK) (Middle Region) Peptide (ABIN5513207)

Antigène

IKK alpha (CHUK) (conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK))

Origine

Humain

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Séquence

    GRRQGDLMES LEQRAIDLYK QLKHRPSDHS YSDSTEMVKI IVHTVQSQDR

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti- CHUK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    IKK alpha (CHUK) (conserved Helix-Loop-Helix Ubiquitous Kinase (CHUK))

    Sujet

    This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor.

    Alias Symbols: IKK1, IKKA, IKBKA, TCF16, NFKBIKA, IKK-alpha

    Protein Size: 745

    ID gène

    1147

    NCBI Accession

    NM_001278, NP_001269

    UniProt

    O15111
Vous êtes ici:
Chat with us!